New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting to quickly uncover issues and reduce unplanned downtime

Fluke Unveils Its Most Powerful Acoustic Imagers in a Smaller, Lighter Design

New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting
New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting

Fluke Unveils Its Most Powerful Acoustic Imagers in a Smaller, Lighter Design

New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting
New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting

Eindhoven, Netherlands, Nov. 02, 2026 (GLOBE NEWSWIRE) — The costliest threats to productivity and profitability are often the ones maintenance teams can’t see. Hidden compressed air leaks waste energy around the clock, while developing electrical and mechanical issues can escalate into safety incidents, equipment failures and unplanned downtime. As industrial organizations face rising energy costs, growing reliability expectations and ongoing workforce shortages, identifying these issues quickly has become more critical than ever.

Organizations need technologies that can uncover hidden issues faster, simplify inspections and enable more confident maintenance decisions. To meet that need, Fluke today introduced the Fluke ii1050 and ii1030 Acoustic Imagers, a new generation of imaging designed to deliver greater acoustic performance in a significantly smaller, lighter platform while simplifying the path from detection to action.

Approximately 40% smaller than previous-generation models and weighing just 1.2 kilograms, the ii1050 and ii1030 make long inspections more comfortable and confined or hard-to-reach areas easier to access. Despite the significantly smaller form factor, the imagers retain the same-size display, now with an anti-glare screen for improved visibility, while an IP54-rated design provides greater protection for demanding industrial environments.

Equipped with 202 microphones, up from 64 in previous-generation models, the cameras can detect fainter sounds and pinpoint their source with greater precision. A high-resolution 13-megapixel camera provides clear visual context, while on-device reporting and an integrated flashlight help teams inspect, diagnose, and document issues in the field. Support for the new TC03A plug-in thermal camera adds thermal imaging to the inspection workflow, giving technicians additional visual context when investigating equipment conditions.

“Maintenance is increasingly less about responding to failures reactively and more about preventing them,” said Tako Feron, Senior Product Manager, Acoustic Imaging, at Fluke. “More complex work means experienced technicians are increasingly scarce, so teams need technologies that turn complex data into clear, insights in the field. The Fluke ii1050 and ii1030 reveal issues that might otherwise go undetected and present information in a way that is intuitive and relevant to the user, enabling faster, more confident decisions on the job. This also supports sustainability by reducing energy waste, improving asset reliability and reducing costly disruptions.”

The ii1050 and ii1030 enable maintenance teams to quickly locate compressed air, gas and vacuum leaks, detect electrical partial discharge, and identify developing mechanical issues from a safe distance. By transforming sound into clear visual insights, the cameras accelerate troubleshooting, support more confident maintenance decisions and help organizations improve reliability while reducing energy waste.

The Fluke ii1050 and ii1030 give maintenance teams the tools to:

  • Find compressed air and gas leaks earlier to reduce energy waste and operating costs.
  • Detect partial discharge from a safe distance to identify electrical issues before they escalate.
  • Identify developing mechanical issues before they lead to equipment failure and costly unplanned downtime
  • Inspect more assets in less time with enhanced acoustic performance and a smaller, lighter design.
  • Turn findings into action faster with on-device tools to assess, prioritize and report inspection results.

The ii1050 and ii1030 combine leak detection, partial-discharge inspection and mechanical anomaly detection in a single platform, enabling maintenance teams to move from inspection to action faster while supporting reliability, safety and energy-efficiency initiatives.

To learn more about the new Acoustic Imagers, please visit the ii1050 and ii1030 product pages at Fluke.com.

About Fluke
Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measurement and condition monitoring. Fluke customers include technicians, engineers, electricians, maintenance managers and metrologists who install, troubleshoot and maintain industrial, electrical and electronic equipment and calibration processes.

FLUKE is a registered trademark of Fluke Corporation. For more information, visit www.fluke.com.

Media Contacts:
Olivia Kline
Fluke Corporation
olivia.kline@fluke.com

Dave Smith
Fluke Corporation
dave.smith@fluke.com

Q: How do the ii1050 and ii1030 help organizations improve reliability and reduce energy waste?
A: The ii1050 and ii1030 help organizations identify issues that often go unnoticed until they become costly problems. By revealing hidden air and gas leaks, detecting partial discharge activity and identifying developing mechanical issues early, maintenance teams can prioritize corrective action, reduce energy losses, improve asset reliability and avoid unplanned downtime.

Q: How do the ii1050 and ii1030 help maintenance teams do more with fewer resources?
A: The ii1050 and ii1030 combine advanced acoustic imaging, thermal imaging support and on-device reporting in a smaller, lighter design that simplifies inspections and accelerates decision-making. By helping users find issues faster, inspect more assets in less time and document results directly in the field, the cameras improve technician productivity while reducing workflow complexity.

Q: How do the Fluke ii1050 and ii1030 differ from other Fluke acoustic imagers?
A: The ii1050 and ii1030 are Fluke’s most capable acoustic imagers to date, combining enhanced acoustic performance, expanded diagnostic capabilities and streamlined reporting in a significantly smaller, lighter design. Compared to previous-generation models, they feature a 202-microphone array, up from 64 microphones, improving the ability to detect and pinpoint smaller, fainter and more closely spaced sound sources. The cameras also introduce on-device reporting, thermal imaging support, an integrated flashlight, enhanced LeakQ™ and PDQ™ algorithms, expanded storage capacity and improved environmental protection, helping maintenance teams inspect more assets, make faster decisions and document findings more efficiently.

Attachments

CONTACT: Olivia Kline
Fluke Corporation
olivia.kline@fluke.com

New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting to quickly uncover issues and reduce unplanned downtime

Fluke Unveils Its Most Powerful Acoustic Imagers in a Smaller, Lighter Design

New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting
New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting

Fluke Unveils Its Most Powerful Acoustic Imagers in a Smaller, Lighter Design

New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting
New Fluke ii1050 and ii1030 acoustic imagers combine advanced detection, thermal imaging support, and on-device reporting

Eindhoven, Netherlands, Nov. 02, 2026 (GLOBE NEWSWIRE) — The costliest threats to productivity and profitability are often the ones maintenance teams can’t see. Hidden compressed air leaks waste energy around the clock, while developing electrical and mechanical issues can escalate into safety incidents, equipment failures and unplanned downtime. As industrial organizations face rising energy costs, growing reliability expectations and ongoing workforce shortages, identifying these issues quickly has become more critical than ever.

Organizations need technologies that can uncover hidden issues faster, simplify inspections and enable more confident maintenance decisions. To meet that need, Fluke today introduced the Fluke ii1050 and ii1030 Acoustic Imagers, a new generation of imaging designed to deliver greater acoustic performance in a significantly smaller, lighter platform while simplifying the path from detection to action.

Approximately 40% smaller than previous-generation models and weighing just 1.2 kilograms, the ii1050 and ii1030 make long inspections more comfortable and confined or hard-to-reach areas easier to access. Despite the significantly smaller form factor, the imagers retain the same-size display, now with an anti-glare screen for improved visibility, while an IP54-rated design provides greater protection for demanding industrial environments.

Equipped with 202 microphones, up from 64 in previous-generation models, the cameras can detect fainter sounds and pinpoint their source with greater precision. A high-resolution 13-megapixel camera provides clear visual context, while on-device reporting and an integrated flashlight help teams inspect, diagnose, and document issues in the field. Support for the new TC03A plug-in thermal camera adds thermal imaging to the inspection workflow, giving technicians additional visual context when investigating equipment conditions.

“Maintenance is increasingly less about responding to failures reactively and more about preventing them,” said Tako Feron, Senior Product Manager, Acoustic Imaging, at Fluke. “More complex work means experienced technicians are increasingly scarce, so teams need technologies that turn complex data into clear, insights in the field. The Fluke ii1050 and ii1030 reveal issues that might otherwise go undetected and present information in a way that is intuitive and relevant to the user, enabling faster, more confident decisions on the job. This also supports sustainability by reducing energy waste, improving asset reliability and reducing costly disruptions.”

The ii1050 and ii1030 enable maintenance teams to quickly locate compressed air, gas and vacuum leaks, detect electrical partial discharge, and identify developing mechanical issues from a safe distance. By transforming sound into clear visual insights, the cameras accelerate troubleshooting, support more confident maintenance decisions and help organizations improve reliability while reducing energy waste.

The Fluke ii1050 and ii1030 give maintenance teams the tools to:

  • Find compressed air and gas leaks earlier to reduce energy waste and operating costs.
  • Detect partial discharge from a safe distance to identify electrical issues before they escalate.
  • Identify developing mechanical issues before they lead to equipment failure and costly unplanned downtime
  • Inspect more assets in less time with enhanced acoustic performance and a smaller, lighter design.
  • Turn findings into action faster with on-device tools to assess, prioritize and report inspection results.

The ii1050 and ii1030 combine leak detection, partial-discharge inspection and mechanical anomaly detection in a single platform, enabling maintenance teams to move from inspection to action faster while supporting reliability, safety and energy-efficiency initiatives.

To learn more about the new Acoustic Imagers, please visit the ii1050 and ii1030 product pages at Fluke.com.

About Fluke
Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measurement and condition monitoring. Fluke customers include technicians, engineers, electricians, maintenance managers and metrologists who install, troubleshoot and maintain industrial, electrical and electronic equipment and calibration processes.

FLUKE is a registered trademark of Fluke Corporation. For more information, visit www.fluke.com.

Media Contacts:
Olivia Kline
Fluke Corporation
olivia.kline@fluke.com

Dave Smith
Fluke Corporation
dave.smith@fluke.com

Q: How do the ii1050 and ii1030 help organizations improve reliability and reduce energy waste?
A: The ii1050 and ii1030 help organizations identify issues that often go unnoticed until they become costly problems. By revealing hidden air and gas leaks, detecting partial discharge activity and identifying developing mechanical issues early, maintenance teams can prioritize corrective action, reduce energy losses, improve asset reliability and avoid unplanned downtime.

Q: How do the ii1050 and ii1030 help maintenance teams do more with fewer resources?
A: The ii1050 and ii1030 combine advanced acoustic imaging, thermal imaging support and on-device reporting in a smaller, lighter design that simplifies inspections and accelerates decision-making. By helping users find issues faster, inspect more assets in less time and document results directly in the field, the cameras improve technician productivity while reducing workflow complexity.

Q: How do the Fluke ii1050 and ii1030 differ from other Fluke acoustic imagers?
A: The ii1050 and ii1030 are Fluke’s most capable acoustic imagers to date, combining enhanced acoustic performance, expanded diagnostic capabilities and streamlined reporting in a significantly smaller, lighter design. Compared to previous-generation models, they feature a 202-microphone array, up from 64 microphones, improving the ability to detect and pinpoint smaller, fainter and more closely spaced sound sources. The cameras also introduce on-device reporting, thermal imaging support, an integrated flashlight, enhanced LeakQ™ and PDQ™ algorithms, expanded storage capacity and improved environmental protection, helping maintenance teams inspect more assets, make faster decisions and document findings more efficiently.

Attachments

CONTACT: Olivia Kline
Fluke Corporation
olivia.kline@fluke.com

Update on discussions with financial partners

Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces, further to its latest communications, that discussions with its financial partners are ongoing with a view to finalizing its refinancing.

The Group will keep the market informed during November of the outcome of the negotiations with its financial partners.

Next event:

2026 annual sales
February 4, 2027 after market close

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 100 years, with 2,746 employees worldwide, we continuously innovate and devote 10% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in Compartment B of Euronext Paris and generated revenue of €786 million in 2025. For more information, please visit www.guerbet.com.

Forward-looking statements

Certain information contained in this press release is not historical data but constitutes forward-looking statements. These forward-looking statements are based on estimates, forecasts and assumptions including, without limitation, assumptions regarding the Group’s current and future strategy and the economic environment in which the Group
operates. They involve known and unknown risks, uncertainties and other factors, which may result in a significant difference between the Group’s actual performance and results and those presented explicitly or implicitly in these forward-looking statements.

These forward-looking statements are only valid as of the date of this press release and the Group expressly disclaims any obligation or commitment to issue an update or revision of the forward-looking statements contained in this press release to reflect changes in the assumptions, events, conditions or circumstances on which such forward-looking statements are based. Forward-looking statements contained in this press release are for illustrative purposes only. Forward-looking statements and information are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict and generally beyond the control of the Group.

These risks and uncertainties include, but are not limited to, uncertainties inherent in research and development, future clinical data and analyses, including post-marketing analyses, decisions by regulatory authorities, such as the Food and Drug Administration or the European Medicines Agency, whether or not to approve, and when, the application for a drug, process or biological product for one of these candidate products, as well as their labeling decisions and other factors that may affect the availability or commercial potential of these candidate products. A detailed description of the risks and uncertainties related to the Group’s activities can be found in chapter 4.8 “Risk factors” of the Group’s Universal Registration Document registered by the AMF under number D.25-0220 on April 3, 2025, available on the Group’s website (www.guerbet.com).

Attachment

Update on discussions with financial partners

Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces, further to its latest communications, that discussions with its financial partners are ongoing with a view to finalizing its refinancing.

The Group will keep the market informed during November of the outcome of the negotiations with its financial partners.

Next event:

2026 annual sales
February 4, 2027 after market close

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 100 years, with 2,746 employees worldwide, we continuously innovate and devote 10% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in Compartment B of Euronext Paris and generated revenue of €786 million in 2025. For more information, please visit www.guerbet.com.

Forward-looking statements

Certain information contained in this press release is not historical data but constitutes forward-looking statements. These forward-looking statements are based on estimates, forecasts and assumptions including, without limitation, assumptions regarding the Group’s current and future strategy and the economic environment in which the Group
operates. They involve known and unknown risks, uncertainties and other factors, which may result in a significant difference between the Group’s actual performance and results and those presented explicitly or implicitly in these forward-looking statements.

These forward-looking statements are only valid as of the date of this press release and the Group expressly disclaims any obligation or commitment to issue an update or revision of the forward-looking statements contained in this press release to reflect changes in the assumptions, events, conditions or circumstances on which such forward-looking statements are based. Forward-looking statements contained in this press release are for illustrative purposes only. Forward-looking statements and information are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict and generally beyond the control of the Group.

These risks and uncertainties include, but are not limited to, uncertainties inherent in research and development, future clinical data and analyses, including post-marketing analyses, decisions by regulatory authorities, such as the Food and Drug Administration or the European Medicines Agency, whether or not to approve, and when, the application for a drug, process or biological product for one of these candidate products, as well as their labeling decisions and other factors that may affect the availability or commercial potential of these candidate products. A detailed description of the risks and uncertainties related to the Group’s activities can be found in chapter 4.8 “Risk factors” of the Group’s Universal Registration Document registered by the AMF under number D.25-0220 on April 3, 2025, available on the Group’s website (www.guerbet.com).

Attachment

Amsterdam, 2 November 2026

EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the second tranche of the share buyback program of up to €125 million announced on 26 October 2026 (the “Second Tranche”), the Company has completed the following transactions on Euronext Amsterdam, CBOE DXE, Turquoise Europe and Aquis Exchange Europe:

EURONEXT AMSTERDAM

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 27,208 68.65 1,867,701.75
27 October 2026 29,935 68.74 2,057,780.05
28 October 2026 25,465 70.11 1,785,437.20
29 October 2026 25,075 71.13 1,783,473.60
30 October 2026 25,150 71.17 1,789,991.80
TOTAL 132,833   9,284,384.40

CBOE DXE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 17,370 68.64 1,192,285.65
27 October 2026 21,298 68.76 1,464,433.20
28 October 2026 25,450 70.11 1,784,302.85
29 October 2026 25,075 71.12 1,783,365.70
30 October 2026 25,000 71.18 1,779,458.70
TOTAL 114,193   8,003,846.10

TURQUOISE EUROPE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 3,308 68.66 227,117.35
27 October 2026 339 68.10 23,086.60
TOTAL 3,647   250,203.95

AQUIS EXCHANGE EUROPE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 4,019 68.66 275,933.90
27 October 2026 328 68.19 22,367.40
TOTAL 4,347   298,301.30

After these purchases, the total invested amount under the Second Tranche is approximately €18 million for a total amount of 255,020 ordinary shares purchased.

As of 2 November 2026, the Company held in total 7,088,492 ordinary shares in treasury (3.41% of total ordinary issued share capital)1.

A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the Share Buyback section.

1 This corresponds to 1.04% of the total issued share capital including both ordinary shares and special voting shares.

Attachment

Amsterdam, 2 November 2026

EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the second tranche of the share buyback program of up to €125 million announced on 26 October 2026 (the “Second Tranche”), the Company has completed the following transactions on Euronext Amsterdam, CBOE DXE, Turquoise Europe and Aquis Exchange Europe:

EURONEXT AMSTERDAM

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 27,208 68.65 1,867,701.75
27 October 2026 29,935 68.74 2,057,780.05
28 October 2026 25,465 70.11 1,785,437.20
29 October 2026 25,075 71.13 1,783,473.60
30 October 2026 25,150 71.17 1,789,991.80
TOTAL 132,833   9,284,384.40

CBOE DXE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 17,370 68.64 1,192,285.65
27 October 2026 21,298 68.76 1,464,433.20
28 October 2026 25,450 70.11 1,784,302.85
29 October 2026 25,075 71.12 1,783,365.70
30 October 2026 25,000 71.18 1,779,458.70
TOTAL 114,193   8,003,846.10

TURQUOISE EUROPE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 3,308 68.66 227,117.35
27 October 2026 339 68.10 23,086.60
TOTAL 3,647   250,203.95

AQUIS EXCHANGE EUROPE

Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€)
26 October 2026 4,019 68.66 275,933.90
27 October 2026 328 68.19 22,367.40
TOTAL 4,347   298,301.30

After these purchases, the total invested amount under the Second Tranche is approximately €18 million for a total amount of 255,020 ordinary shares purchased.

As of 2 November 2026, the Company held in total 7,088,492 ordinary shares in treasury (3.41% of total ordinary issued share capital)1.

A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the Share Buyback section.

1 This corresponds to 1.04% of the total issued share capital including both ordinary shares and special voting shares.

Attachment

  • Transaction strengthens balance sheet with pre-tax cash proceeds of approximately $1.45 billion, before customary closing adjustments

HOUSTON and LONDON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR, “the Company”), an energy technology company, announced Monday the successful sale of its Waygate Technologies business to Hexagon. The all-cash transaction is valued at approximately $1.45 billion, before customary closing adjustments.

The sale encompasses Waygate Technologies’ remote visual inspection, ultrasound, radiography, and imaging solutions portfolios, and all assets of the business, including intellectual property, footprint and resources.

This divestiture reinforces the Company’s commitment to disciplined portfolio management, enhances the durability of earnings and cash flow, and further strengthens the Company’s balance sheet.

About Baker Hughes
Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com.

For more information, please contact:

Media Relations

Adrienne M. Lynch
+1 713-906-8407
adrienne.lynch@bakerhughes.com

Investor Relations

Chase Mulvehill
+1 346-297-2561
investor.relations@bakerhughes.com
   

  • Transaction strengthens balance sheet with pre-tax cash proceeds of approximately $1.45 billion, before customary closing adjustments

HOUSTON and LONDON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR, “the Company”), an energy technology company, announced Monday the successful sale of its Waygate Technologies business to Hexagon. The all-cash transaction is valued at approximately $1.45 billion, before customary closing adjustments.

The sale encompasses Waygate Technologies’ remote visual inspection, ultrasound, radiography, and imaging solutions portfolios, and all assets of the business, including intellectual property, footprint and resources.

This divestiture reinforces the Company’s commitment to disciplined portfolio management, enhances the durability of earnings and cash flow, and further strengthens the Company’s balance sheet.

About Baker Hughes
Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com.

For more information, please contact:

Media Relations

Adrienne M. Lynch
+1 713-906-8407
adrienne.lynch@bakerhughes.com

Investor Relations

Chase Mulvehill
+1 346-297-2561
investor.relations@bakerhughes.com
   

Octopus Future Generations VCT plc

Total Voting Rights and Capital

Octopus Future Generations VCT plc (‘the Company’) announces that as at 31 October 2026 its issued share capital consists of 63,282,656 Ordinary shares of 0.1p each. The Company holds no shares in treasury and the total voting rights in the Company are 63,282,656.

The above figure of 63,282,656‬‬‬ may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

For further information please contact:

Ronan Goggin
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800AL71Z7N2O58N66

Octopus Future Generations VCT plc

Total Voting Rights and Capital

Octopus Future Generations VCT plc (‘the Company’) announces that as at 31 October 2026 its issued share capital consists of 63,282,656 Ordinary shares of 0.1p each. The Company holds no shares in treasury and the total voting rights in the Company are 63,282,656.

The above figure of 63,282,656‬‬‬ may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

For further information please contact:

Ronan Goggin
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800AL71Z7N2O58N66

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.